ArticleInternational journal of molecular sciences2021

Targeting SIRT2 Sensitizes Melanoma Cells to Cisplatin via an EGFR-Dependent Mechanism.

Iwona Karwaciak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.